Chengxun Su

Ms. Chengxun Su

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
CSChengxun Su
Chengxun Su
YCYon Jin Chuah
Yon Jin Chuah
HOHong Boon Ong
Hong Boon Ong
HTHui Min Tay
Hui Min Tay
RDRinkoo Dalan
Rinkoo Dalan
HHHan Wei Hou
Han Wei Hou
Incorporation of extracellular matrix (ECM) and hydrogel in microfluidic 3D cell culture platforms is important to create a physiological microenvironment for cell morphogenesis and to establish 3D co-culture models by hydrogel compartmentalization. Here, we describe a simple and scalable ECM patterning method for microfluidic cell cultures by achieving hydrogel confinement due to the geometrical expansion of channel heights (stepped height features) and capillary burst valve (CBV) effects. We first demonstrate a sequential “pillar-free” hydrogel patterning to form adjacent hydrogel lanes in enclosed microfluidic devices, which can be further multiplexed with one to two stepped height features. Next, we developed a novel “spheroid-in-gel” culture device that integrates (1) an on-chip hanging drop spheroid culture and (2) a single “press-on” hydrogel confinement step for rapid ECM patterning in an open-channel microarray format. The initial formation of breast cancer (MCF-7) spheroids was achieved by hanging a drop culture on a patterned polydimethylsiloxane (PDMS) substrate. Single spheroids were then directly encapsulated on-chip in individual hydrogel islands at the same positions, thus, eliminating any manual spheroid handling and transferring steps. As a proof-of-concept to perform a spheroid co-culture, endothelial cell layer (HUVEC) was formed surrounding the spheroid-containing ECM region for drug testing studies. Overall, this developed stepped height-based hydrogel patterning method is simple to use in either enclosed microchannels or open surfaces and can be readily adapted for in-gel cultures of larger 3D cellular spheroids or microtissues.

13 February 2024 in ACS Nano
Verified
Journal Article
Closed access
SLSheng Yuan Leong
Sheng Yuan Leong
WLWan Wei Lok
Wan Wei Lok
KGKah Yee Goh
Kah Yee Goh
HOHong Boon Ong
Hong Boon Ong
HTHui Min Tay
Hui Min Tay
HHHan Wei Hou
Han Wei Hou

24 March 2025 in npj Aging
Verified
Journal Article
Open access
PDF file
CSChengxun Su
Chengxun Su
PWPeter Wang
Peter Wang
NFNigel Foo
Nigel Foo
DHDean Ho
Dean Ho
A hallmark of subclinical metabolic decline is impaired metabolic flexibility, which refers to the ability to switch fuel utilization between glucose and fat according to energy demand and substrate availability. Herein, we propose optimizing metabolic health with digital twins that model an individual’s metabolic flexibility profile to gamify the process of health optimization and predict long-term health outcomes. We explore key characteristics of this approach from technological and socioeconomical perspectives, with the objective of reducing the burden from metabolic disorders through driving behavior change and early detection of metabolic decline.

7 November 2023 in Environmental Science & Technology
Verified
Journal Article
Closed access
MLMelissa Kao Hui Lee
Melissa Kao Hui Lee
HLHong Kit Lim
Hong Kit Lim
CSChengxun Su
Chengxun Su
JKJie Yan Cheryl Koh
Jie Yan Cheryl Koh
MSMagdiel Inggrid Setyawati
Magdiel Inggrid Setyawati
CTChor Yong Tay
Chor Yong Tay

3 August 2026 in PNAS Nexus
Verified
Journal Article
Open access
PWPeter Wang
Peter Wang
AHAlton Hsiung
Alton Hsiung
CFChristiana Fraise
Christiana Fraise
GSGyula Seres
Gyula Seres
LCLi Ming Chong
Li Ming Chong
DHDean Ho
Dean Ho
The rising incidence of antimicrobial resistance (AMR) has threatened global public health with a high mortality rate. In parallel, the de-incentivization for further investment, regulatory constraints, and overuse/misuse of antibiotics have accelerated the progression of AMR. Together, these factors have contributed to the declining efficacy of a wide spectrum of antibiotics and the increasing prevalence of drug resistance that outpaced AMR-specific drug development. More importantly, even with substantial historical investments in antibiotic discovery over several decades, the development of clinically actionable, novel antibiotics has remained limited. In this article, we present the challenges of addressing AMR and outline emerging strategies that may reduce its burden. While advanced therapies, including bacteriophage therapy, have demonstrated promising results, complementary strategies that integrate emerging technologies and engage diverse stakeholders are needed. Building on this vision, we propose the potential role of AI-powered platforms in supporting and accelerating AMR-specific drug development alongside a community-driven approach that engages scientists, policymakers, health economists, clinicians, and patients to help address existing scientific and translational challenges. Furthermore, this article offers an inclusive strategy with key considerations, including educational and public health interventions, government-led programs, and health economics, which together could potentially tackle the threat of AMR along with AI-powered solutions.